In December, following the November US midterm elections, Richard Gallagher, the editor of The Scientist, wrote a hopeful editorial on the future of stem cell funding in the US. In it, he suggested that the Senate was just one vote shy of the 67-33 vote it would need to overturn a Presidential veto on the bill.
He may have been right. Yesterday, the Senate voted 63-34 to approve the Stem Cell Research Enhancement Act. The three... Click to continue